HIV Infection Mechanism Discovered CDC Daily UpdateImportant note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




HIV Infection Mechanism Discovered

Washington Post (10/26/93) P. A13


Researchers at France's Pasteur Institute claim to have discovered how the AIDS virus penetrates and infects blood cells, a finding which could have major implications in the development of a vaccine. The team said it found a "co- receptor" molecule called CD26, which was identified several years ago, but whose function remained a mystery. According to the researchers, CD26 is used by all strains of the virus as a gateway into blood cells. Although they have known for years that HIV adheres to surface receptor molecules known as CD4, scientists still did not know how the virus actually got inside the cells to contaminate them, said Ara Hovanessian, head of the Pasteur Institute team. "The presence and functioning of the CD26 molecule are indispensable for the infection and spread of the virus in the CD4 cells," said a statement from the Institute. "In viral infections, the CD4 serves as the contact point for viral particles, while CD26 serves as the main door." The existence of this second receptor molecule sheds light on possible strategies to develop a vaccine that will "lock out" HIV, said the researchers. "The AIDS virus has always managed to have the key to open the CD4 receptor lock," said Hovanessian. "We hope to be able to develop drugs capable of jamming the CD26 lock so that the AIDS key will no longer fit." Because every strain of the disease uses CD26 to infect cells, researchers hope to develop a universal vaccine. Related Story: New York Times (10/26) P. C1; Wall Street Journal (10/26) P. B18; Philadelphia Inquirer (10/26) P.A7; Washington Times (10/26) P. A3


931026
AD931926


Copyright © 1993 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.